Advertisement

Topics

Pappas Ventures Company Profile

09:57 EDT 21st July 2018 | BioPortfolio

Founded in 1994, Pappas Ventures invests exclusively in the life sciences sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. Most recently, in December 2009, the firm co-founded Afferent Pharmaceuticals, a spinout from Roche that is developing first-in-class treatments for chronic pain. Pappas Ventures has more than $350 million in capital under management, and has guided the launch and/or development of more than 50 life sciences companies, including Cerexa (acquired by Forest Laboratories), Peninsula Pharmaceuticals (acquired by Johnson & Johnson), Syntonix (acquired by Biogen IDEC), NuVasive (IPO), and Arena Pharmaceuticals (IPO). For more information about Pappas Ventures, please visit www.pappasventures.com.


News Articles [301 Associated News Articles listed on BioPortfolio]

Chicago Tribune: Pappas Is 'Strongly Endorsed' For Cook County Treasurer

Maria Pappashas held the post of Treasurer of Cook Countysince 1998. "During 20 years as treasurer, Pappas has reduced office headcount from 250 Read more...

Pappas: $94 million in property tax refunds available on new website

Pappas: $94 million in property tax refunds available on new website Read more...

Mathers joins Pappas

Mathers joins Pappas Capital as partner

RubiconMD wraps up $13.8M Series B to connect PCPs and specialists

The round, which was led by HLM Ventures and Optum Ventures, included participation from Centene Corporation, Alma Mundi Ventures and others.

Eko raises $5mm in Series A round

Eko (cardiac monitoring devices) raised $5mm in its Series A financing led by ARTIS Ventures, which was joined by Strategic Partners, Dreamlt Ventures, 1812 Ventures, and founder.org.

StrideBio gets $15.7mm via Series A

StrideBio Inc. (developing novel adeno-associated viral (AAV) vectors for in vivo gene therapies aimed at rare diseases) raised $15.7mm in an oversubscribed Series A financing led by Hatteras Venture ...

Eko raises $5M Series A to add staff, support clinical studies for digital stethoscope

ARTIS Ventures led the Series A round. Other investors that took part included Strategic Partners, Dreamlt Ventures, 1812 Ventures, and FOUNDER.org.

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Avant ex [B4 Ventures LLC]

B4 Brands: Avant EX Instant Hand Sanitizer

Avant foaming hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free

Avant original instant hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Original Instant Hand Sanitizer

Aterra antibacterial hand wash [B4 Ventures LLC]

B4 Brands: Aterra Antibacterial Hand Soap

Avant original - fragrance free [B4 Ventures LLC]

B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer

PubMed Articles [9 Associated PubMed Articles listed on BioPortfolio]

January 2018 Corrigendum.

Corrections to an article published in the March 2013 issue of JOSPT: Xergia SA, Pappas E, Zampeli F, Georgiou S, Georgoulis AD. Asymmetries in functional hop tests, lower extremity kinematics, and is...

Outsourcing of Academic Clinical Laboratories: Experiences and Lessons From the Association of Pathology Chairs Laboratory Outsourcing Survey.

American hospitals are increasingly turning to service outsourcing to reduce costs, including laboratory services. Studies of this practice have largely focused on nonacademic medical centers. In cont...

Tiny Conveyance: Micro- and Nanorobots Prepare to Advance Medicine.

In the science-fiction classic Fantastic Voyage [1], a shrink-ray zaps a submarine and the crew within it, and the resulting microscopic vehicle ventures inside a human body to destroy a blood clot an...

Evaluating Resident Perspectives on International Humanitarian Missions.

Opportunities for international missions are highly sought after by medical students, residents, and attending plastic surgeons. The educational benefits and ethical considerations of trainees partici...

With tree nut sensitization, take the current when it serves, or lose our ventures.

Tree nut allergy affects approximately 1.4-2.3%, depending on the study methodology, patient age, and region in which the study was conducted.1,2 Tree nut allergy can be severe, and tends to persist t...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation of a Digital Microscope for Malaria

Light microscopy, which is based on century-old technology, remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalaria...

Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)

Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...

Companies [544 Associated Companies listed on BioPortfolio]

Pappas Ventures

Founded in 1994, Pappas Ventures invests exclusively in the life sciences sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. Mos...

At Pappas Ventures

Pappas Ventures, our sole focus is investing in the life sciences – biotechnology, specialty pharmaceuticals, drug delivery, medical devices and related ventures. Our success, however, is not simply...

CoLucid Pharmaceuticals, Inc.

CoLucid was founded in 2005 by Pappas Ventures to advance innovative drug candidates with the potential to provide safe and effective treatment for CNS disorders. The companyâ€...

CardioDx, Inc.

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, is committed to developing clinically validated tests that empower clinicians to better tailor care t...

Afferent Pharmaceuticals

Afferent Pharmaceuticals is focused on developing first-in-class medicines to treat chronic pain by targeting P2X3 receptors in nerve fibers. Research shows that P2X3-containin...

More Information about "Pappas Ventures" on BioPortfolio

We have published hundreds of Pappas Ventures news stories on BioPortfolio along with dozens of Pappas Ventures Clinical Trials and PubMed Articles about Pappas Ventures for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pappas Ventures Companies in our database. You can also find out about relevant Pappas Ventures Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record